| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S007020070089 |
| P698 | PubMed publication ID | 11215758 |
| P50 | author | Abraham Weizman | Q27020194 |
| P2093 | author name string | I Gil-Ad | |
| Mosberg | |||
| D Offen | |||
| E Melamed | |||
| R Galili | |||
| P433 | issue | 4 | |
| P921 | main subject | neurotoxicity | Q3338704 |
| P304 | page(s) | 479-490 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Neural Transmission | Q15750921 |
| P1476 | title | Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia | |
| P478 | volume | 107 |
| Q82647139 | Alternative complement pathway in schizophrenia |
| Q35044374 | Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms |
| Q33198754 | Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors. |
| Q34391577 | Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders |
| Q38438041 | Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations |
| Q39921323 | Combining the Antipsychotic Drug Haloperidol and Environmental Enrichment after Traumatic Brain Injury Is a Double-Edged Sword |
| Q37416345 | Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism |
| Q44401029 | Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism |
| Q44499703 | Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats |
| Q44058159 | Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat. |
| Q35376749 | Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficits |
| Q48221235 | Effects of chronic haloperidol and/or clozapine on oxidative stress parameters in rat brain. |
| Q40727959 | Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms. |
| Q36687842 | Evidence for neuroprotective effects of antipsychotic drugs: implications for the pathophysiology and treatment of schizophrenia |
| Q35974641 | Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice |
| Q46931420 | Haloperidol induces apoptosis via the sigma2 receptor system and Bcl-XS. |
| Q81341404 | Hyperactivation of the alternative complement cascade in schizophrenia |
| Q33802645 | Medication-Induced Tardive Dyskinesia: A Review and Update |
| Q24568289 | N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities |
| Q36939735 | N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology |
| Q51947455 | Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis. |
| Q36458436 | Neuroprotective agents in schizophrenia and affective disorders |
| Q35017644 | Oxidative mechanisms and tardive dyskinesia |
| Q44288274 | Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia |
Search more.